InvestSMART

Acrux Limited (ASX: ACR) - Announcements

Current share price for ACR : $0.011 0.001 (5%)+

ASX company news and announcements for Acrux Limited (ACR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Acrux Limited (ACR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Acrux Limited (ACR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Acrux Limited (ACR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$6 Application for quotation of securities - ACR 31 Mar 2023 9:25AM $0.059 $0.011 fallen by 82.20%
$6 Notification of cessation of securities - ACR 31 Mar 2023 9:14AM $0.059 $0.011 fallen by 82.20%
$6 Appendix 3Y Buumley 9 Mar 2023 9:57AM $0.062 $0.011 fallen by 83.06%
$6 Appendix 3Y Dobinson 1 Mar 2023 11:40AM $0.061 $0.011 fallen by 82.79%
$6 Appendix 3Y Brumley 1 Mar 2023 11:34AM $0.061 $0.011 fallen by 82.79%
$6 Application for quotation of securities - ACR 1 Mar 2023 11:29AM $0.061 $0.011 fallen by 82.79%
$6 Appendix 4D and Half Year Report 23 Feb 2023 12:36PM $0.063 $0.011 fallen by 83.33%
$6 Notification regarding unquoted securities - ACR 13 Feb 2023 1:42PM $0.071 $0.011 fallen by 85.21%
$6 Application for quotation of securities - ACR 13 Feb 2023 1:38PM $0.071 $0.011 fallen by 85.21%
$6 Quarterly Activities / Appendix 4C Cashflow Report 30 Jan 2023 9:20AM $0.078 $0.011 fallen by 86.54%
$6 Gedeon Richter buyout Lenzetto Royalties for EUR4.1million 23 Jan 2023 8:59AM $0.070 $0.011 fallen by 85%
$6 Positive FDA Remote Regulatory Assessment 19 Jan 2023 9:20AM $0.068 $0.011 fallen by 84.56%
$6 Launch of prilocaine and lidocaine cream in United States 21 Dec 2022 8:29AM $0.070 $0.011 fallen by 85%
$6 Mutual Termination of Co-Development Agreement 15 Dec 2022 11:33AM $0.077 $0.011 fallen by 86.36%
$6 Appendix 3Y - Brooke 1 Dec 2022 9:15AM $0.075 $0.011 fallen by 86%
$6 Appendix 3Y - Dobinson 1 Dec 2022 9:14AM $0.075 $0.011 fallen by 86%
$6 Appendix 3Y - Brumley 1 Dec 2022 9:13AM $0.075 $0.011 fallen by 86%
$6 Application for quotation of securities - ACR 1 Dec 2022 9:12AM $0.075 $0.011 fallen by 86%
$6 Appendix 3Y Dobinson 25 Nov 2022 2:02PM $0.067 $0.011 fallen by 84.33%
$6 Appendix 3Y Brooke 25 Nov 2022 2:01PM $0.067 $0.011 fallen by 84.33%
$6 Appendix 3Y Oldham 25 Nov 2022 2:00PM $0.067 $0.011 fallen by 84.33%
$6 Appendix 3Y Brumley 25 Nov 2022 1:59PM $0.067 $0.011 fallen by 84.33%
$6 Notification regarding unquoted securities - ACR 25 Nov 2022 1:53PM $0.067 $0.011 fallen by 84.33%
$6 Results of AGM 23 Nov 2022 1:34PM $0.067 $0.011 fallen by 84.33%
$6 Chairman and CEO address to AGM 23 Nov 2022 8:22AM $0.067 $0.011 fallen by 84.33%

201 - 225 of 699 results

Page 9 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.